Compounds of formula IA and IB are new ##STR1## where the variables R.sup.1 through R.sup.10 have the values set forth herein. Such compounds have use in treating diseases such as obesity and type II diabetes, and may be provided as pharmaceutical formulations in conjunction with a pharmaceutically acceptable carrier.

Os compostos da fórmula IA e IB são o ## novo do ## STR1 onde as variáveis R.sup.1 com R.sup.10 mandam os valores determinar nisto. Tais compostos têm o uso em doenças de tratamento tais como o obesity e o tipo diabetes de II, e podem ser fornecidos como formulations pharmaceutical conjuntamente com um portador pharmaceutically aceitável.

 
Web www.patentalert.com

< LSR receptor, activity, cloning, and uses for diagnosing, preventing and/or treating obesity and related risks or complications

< Melanocortin-3 receptor deficient cells, non-human trangenic animals and methods of selecting compounds which regulate body weight

> Coated particles, methods of making and using

> Amphiphilic polymers and polypeptide conjugates comprising same

~ 00088